The Meals and Drug Administration permitted a second COVID-19 booster dose for these age 50 and up on Tuesday.

The choice applies to each the Pfizer and Moderna vaccines. Nevertheless, with COVID-19 circumstances nonetheless comparatively low in america, there's "restricted proof" to point how a lot one other booster would assist, as Facilities for Illness Management and Prevention (CDC) knowledge signifies that two doses and a booster nonetheless present sturdy safety towards extreme infections and dying, the Related Press reported.

COVID-19 circumstances within the U.S. have been low, with knowledge from Reuters displaying circumstances are at the moment solely at 4 % of their peak from the start of this 12 months, when the Omicron variant led a big spike in circumstances. Nevertheless, there are nonetheless worries that the BA.2 sub-variant of Omicron may result in one other spike in circumstances, a pattern that has already been seen in some European nations like France, the U.Ok. and Italy.

The FDA recommends folks 50 and older obtain their second booster not less than 4 months after receiving the primary one, in response to a information launch from the company. It has additionally permitted the fourth dose for these 18 and older who've "sure sorts of immunocompromise" and people 12 and older "who've undergone strong organ transplantation, or who're residing with situations which are thought-about to have an equal stage of immunocompromise."

It is a growing story and can be up to date as extra info turns into obtainable.

Replace 03/29/22 11:33 a.m. ET: This story was up to date so as to add extra info and background.

FDA Approves Another COVID-19 Booster
The FDA permitted one other COVID-19 booster for these 50 and up. Above, a well being employee prepares the Pfizer COVID-19 vaccine on March 22 in San Salvador, El Salvador.Photograph by Emerson Flores/APHOTOGRAFIA/Getty Pictures